EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of anemia in patients under radiotherapy with subcutaneous epoetenium alpha 10,000 IU three times a week and 40,000 IU once a week



Treatment of anemia in patients under radiotherapy with subcutaneous epoetenium alpha 10,000 IU three times a week and 40,000 IU once a week



Oncologia (Madrid) 25(8): 40-45



Purpose: We present the results of the treatment of anemia in cancer patients under radiotherapy with two different administration schedules of epoetin alfa. Material and methods: One hundred and eighteen anemic patients were treated with erythropoietin. Fifty seven patients were treated with 10.000 IU three-times a week (group A) and sixty one patients with 40.000 IU once a week (group B). Hemoglobin levels, transfusions requirements and quality of life were evaluated. Results: The hemoglobin increase was 2.1 g/dL in group A, and 2.2 g/dL in group B. The mean duration of the treatment was 5.5 and 5.3 weeks, respectively. Three patients of group A required transfusions during the study. We observed a favorable evolution of the quality of life for the sample as a whole. Conclusions: Epoetin alfa once a week or three-times a week is an effective treatment to increase the hemoglobin level in anemic cancer patients under radiotherapy.

(PDF 0-2 workdays service: $29.90)

Accession: 035980951

Download citation: RISBibTeXText



Related references

A randomized trial of daily interferon alfa-2b in combination with ribavirin, vs three times a week for one month, followed by three times a week for one year in relapse or nonresponder patients. Hepatology 32(4 Pt 2): 442A, October, 2000

A trial of subcutaneous administration of darbepoetin alfa once every other week for the treatment of anemia in peritoneal dialysis patients. Journal of Nephrology 17(5): 687-692, 2004

The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials. Medicinski Pregled 60(3-4): 123-127, 2007

A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden. Journal of Medical Economics 16(6): 756-762, 2014

A randomized trial of interferon alfa-2B, daily vs three times a week for one month, followed by three times a week for one year in combination with ribavirin in patients who have failed a previous course of interferon. Hepatology 28(4 PART 2): 574A, 1998

Twice per week treatment versus five times per week. A radiotherapeutic clinical trial. British Journal of Radiology 46(545): 350-353, 1973

Twice per week treatment vs 5 times per week a radio therapeutic clinical trial. British Journal of Radiology 46(545): 350-353, 1973

A comparison of induction versus three times a week interferon-alpha treatment plus ribavirin for patients with chronic hepatitis C who are treatment naive. Hepatology 30(4 PART 2): 616A, 1999

A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoetin alfa in CKD patients with anemia. Clinical Journal of the American Society of Nephrology 5(4): 598-606, 2010

Three times a week LAAM equals seven times a week methadone: a preliminary report of a control study. 1974. Nida Research Monograph: 90-91, 1976

Treatment of anemia of chronic renal failure in the pre-dialysis stage with low dose once-a-week subcutaneous erythropoietin. Journal of the American Society of Nephrology 5(3): 345, 1994

Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study. Bmc Neurology 17(1): 57-57, 2017

The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients. Journal of Viral Hepatitis 12(1): 91-95, 2005

Three times a week and five times a week walking exercise frequencies are equally effective in improving walking capacity in experimental peripheral artery disease. Atherosclerosis 252: E59-E60, 2016

NOA-08 randomized phase III trial of 1-week-on/1-week-off temozolomide versus involved-field radiotherapy in elderly (older than age 65) patients with newly diagnosed anaplastic astrocytoma or glioblastoma (Methusalem). Journal of Clinical Oncology 28(18_suppl): Lba2001-Lba2001, 2016